Connection

William Groh to Male

Back to Details
This is a "connection" page, showing publications William Groh has written about Male.
William Groh
Connection Strength
0.416
Male
  1. Change in cognitive function over 12 months among patients with an implantable cardioverter-defibrillator. J Cardiovasc Nurs. 2013 Nov-Dec; 28(6):E28-36.
    View in: PubMed
    Score: 0.024
  2. Arrhythmia management in myotonic dystrophy type 1. JAMA. 2012 Jul 25; 308(4):337-8; author reply 338.
    View in: PubMed
    Score: 0.022
  3. Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population. J Cardiovasc Electrophysiol. 2011 Dec; 22(12):1369-75.
    View in: PubMed
    Score: 0.021
  4. A retrospective analysis of proceduralist-directed, nurse-administered propofol sedation for implantable cardioverter-defibrillator procedures. Heart Rhythm. 2012 Mar; 9(3):342-6.
    View in: PubMed
    Score: 0.021
  5. Survival and CTG repeat expansion in adults with myotonic dystrophy type 1. Muscle Nerve. 2011 May; 43(5):648-51.
    View in: PubMed
    Score: 0.020
  6. Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1. Am Heart J. 2010 Dec; 160(6):1137-41, 1141.e1.
    View in: PubMed
    Score: 0.020
  7. The electrocardiogram: a useful screening test for cardiac involvement in some but not all of the muscular dystrophies. Heart Rhythm. 2010 Oct; 7(10):1489-90.
    View in: PubMed
    Score: 0.019
  8. Arrhythmia exacerbation after sodium channel blockade in myotonic dystrophy type 1. Muscle Nerve. 2009 Nov; 40(5):901-2.
    View in: PubMed
    Score: 0.018
  9. Physical function of patients with implantable cardioverter-defibrillators. J Cardiovasc Nurs. 2009 Sep-Oct; 24(5):398-409.
    View in: PubMed
    Score: 0.018
  10. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med. 2008 Jun 19; 358(25):2688-97.
    View in: PubMed
    Score: 0.017
  11. Pacemaker/implantable cardioverter-defibrillator problem: right ventricular lead missensing in a biventricular implantable cardioverter-defibrillator. Heart Rhythm. 2008 Jan; 5(1):158-9.
    View in: PubMed
    Score: 0.016
  12. Characteristics of volunteers responding to emergencies in the Public Access Defibrillation Trial. Resuscitation. 2007 Feb; 72(2):193-9.
    View in: PubMed
    Score: 0.015
  13. Familial clustering of muscular and cardiac involvement in myotonic dystrophy type 1. Muscle Nerve. 2005 Jun; 31(6):719-24.
    View in: PubMed
    Score: 0.014
  14. Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I. Am Heart J. 2004 Feb; 147(2):224-7.
    View in: PubMed
    Score: 0.012
  15. Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade. J Cardiovasc Electrophysiol. 2003 Nov; 14(11):1245-7.
    View in: PubMed
    Score: 0.012
  16. A comparison of first-responder automated external defibrillator (AED) application rates and characteristics of AED training. Prehosp Emerg Care. 2003 Oct-Dec; 7(4):453-7.
    View in: PubMed
    Score: 0.012
  17. Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1. Ann Noninvasive Electrocardiol. 2003 Jul; 8(3):227-32.
    View in: PubMed
    Score: 0.012
  18. Attitudes of law enforcement officers regarding automated external defibrillators. Acad Emerg Med. 2002 Jul; 9(7):751-3.
    View in: PubMed
    Score: 0.011
  19. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electrophysiol. 2002 May; 13(5):444-8.
    View in: PubMed
    Score: 0.011
  20. Limited response to cardiac arrest by police equipped with automated external defibrillators: lack of survival benefit in suburban and rural Indiana--the police as responder automated defibrillation evaluation (PARADE). Acad Emerg Med. 2001 Apr; 8(4):324-30.
    View in: PubMed
    Score: 0.010
  21. Amiodarone reduces the prevalence of T wave alternans in a population with ventricular tachyarrhythmias. J Cardiovasc Electrophysiol. 1999 Oct; 10(10):1335-9.
    View in: PubMed
    Score: 0.009
  22. Software error resulting in malfunction of an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol. 1999 Jun; 10(6):871-3.
    View in: PubMed
    Score: 0.009
  23. Comparison of the rate-dependent properties of the class III antiarrhythmic agents azimilide (NE-10064) and E-4031: considerations on the mechanism of reverse rate-dependent action potential prolongation. J Cardiovasc Electrophysiol. 1997 May; 8(5):529-36.
    View in: PubMed
    Score: 0.008
  24. Utility of Conventional Electrocardiographic Criteria in Patients With Idiopathic Ventricular?Tachycardia. JACC Clin Electrophysiol. 2017 07; 3(7):669-677.
    View in: PubMed
    Score: 0.008
  25. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol. 1996 Sep 15; 78(6):703-6.
    View in: PubMed
    Score: 0.007
  26. Evaluation of the Genetic Basis of Familial Aggregation of Pacemaker Implantation by a Large Next Generation Sequencing Panel. PLoS One. 2015; 10(12):e0143588.
    View in: PubMed
    Score: 0.007
  27. Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy. Circulation. 2015 May 05; 131(18):1590-8.
    View in: PubMed
    Score: 0.007
  28. Beta-adrenergic blocking property of dl-sotalol maintains class III efficacy in guinea pig ventricular muscle after isoproterenol. Circulation. 1995 Jan 15; 91(2):262-4.
    View in: PubMed
    Score: 0.007
  29. Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region. Heart Rhythm. 2014 May; 11(5):849-55.
    View in: PubMed
    Score: 0.006
  30. A pilot study in hemodialysis of an electrophysiological tool to measure sudden cardiac death risk. Clin Nephrol. 2007 Sep; 68(3):159-64.
    View in: PubMed
    Score: 0.004
  31. Ischemic ventricular arrhythmias during heart failure: a canine model to replicate clinical events. Heart Rhythm. 2005 Sep; 2(9):979-83.
    View in: PubMed
    Score: 0.003
  32. Implementation of community-based public access defibrillation in the PAD trial. Acad Emerg Med. 2005 Aug; 12(8):688-97.
    View in: PubMed
    Score: 0.003
  33. Facile synthesis and initial PET imaging of novel potential heart acetylcholinesterase imaging agents [11C]pyridostigmine and its analogs. Nucl Med Biol. 2004 Oct; 31(7):957-64.
    View in: PubMed
    Score: 0.003
  34. Law Enforcement Agency Defibrillation (LEA-D): proceedings of the National Center for Early Defibrillation Police AED Issues Forum. Prehosp Emerg Care. 2002 Jul-Sep; 6(3):273-82.
    View in: PubMed
    Score: 0.003
  35. Atrial macroreentry involving the myocardium of the coronary sinus: a unique mechanism for atypical flutter. J Cardiovasc Electrophysiol. 1998 Oct; 9(10):1094-9.
    View in: PubMed
    Score: 0.002
  36. Bilateral internal mammary-to-pulmonary artery fistulas after a coronary operation. Ann Thorac Surg. 1994 Jun; 57(6):1642-3.
    View in: PubMed
    Score: 0.002
  37. [5-years experience with pacemaker therapy]. Orv Hetil. 1971 Aug 22; 112(34):2007-10.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.